Sort
59,101 grants matching “hypertension”
Nephrotic Syndrome Rare Disease Clinical Research Network
$1,245,786Matthias Kretzler · University Of Michigan At Ann Arbor · U54 · FY2012 · DK
INHALED NO FOR THE PREVENTION OF CHRONIC LUNG DISEASE
$1,245,274University Of Colorado Denver · U01 · FY2004 · HL
Nephrotic Syndrome Rare Disease Clinical Research Network
$1,244,475Matthias Kretzler · University Of Michigan At Ann Arbor · U54 · FY2013 · DK
SCOR: Impact of Injury on the Immature Pulmonary Circul*
$1,243,855University Of Colorado Denver · P50 · FY2003 · HL
Vascular Determinants of Stage B HF among Hispanics: the role of the Heart-Vascular Interaction
$1,243,724Carlos Jose Rodriguez · Albert Einstein College Of Medicine · R01 · FY2023 · HL
A non-pharmacological multi-modal therapy to improve sleep and cognition and reduce mild cognitive impairment risk
$1,243,520Daniel Gartenberg · Proactive Life, Inc. · R44 · FY2020 · AG
Multiple Chronic COnditions: MultiPle dAta SouRcEs (MC COMPARE)
$1,242,470David A Dorr · Oregon Health & Science University · R01 · FY2023 · AG
1 of 5 ARIC Neurocognitive Study (ARIC-NCS)
$1,242,115Josef Coresh · Johns Hopkins University · U01 · FY2013 · HL
Transmembrane Signaling Mechanisms Involving TRP Channels
$1,242,107Lutz Birnbaumer · National Institute Of Environmental Health Sciences · ZIG · FY2009 · ES
Preventing Cognitive Decline by Reducing BP Target Trial (PCOT)
$1,241,873Miguel A Vazquez · Ut Southwestern Medical Center · R33 · FY2021 · AG
Metabolic effects and mechanisms for heart failure in South Asians
$1,241,180Alka M Kanaya · University Of California, San Francisco · R01 · FY2021 · HL
Nudging Doctors to Collaborate with Pharmacists to Improve Medication Adherence
$1,240,551Ira B Wilson · Brown University · RC4 · FY2010 · AG
1 of 5 ARIC Neurocognitive Study (ARIC-NCS)
$1,240,198Josef Coresh · Johns Hopkins University · U01 · FY2010 · HL
Physiology and Pharmacology of BRS3 (Bombesin-Like Receptor 3)
$1,239,818Marc L Reitman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
$1,239,212Rudolph L Leibel · Columbia University Health Sciences · UH3 · FY2023 · DK
Multiethnic Study of Breast Arterial Calcium Gradation and CVD
$1,239,153Carlos Iribarren · Kaiser Foundation Research Institute · R01 · FY2015 · HL
COBRE for Stress, Trauma and Resilience (STAR)
$1,238,591Laura R Stroud · Miriam Hospital · P20 · FY2025 · GM
Preventing Cognitive Decline by Reducing BP Target Trial (PCOT)
$1,238,148Miguel A Vazquez · Ut Southwestern Medical Center · R33 · FY2022 · AG
Preventing Cognitive Decline by Reducing BP Target Trial (PCOT)
$1,238,148Miguel A Vazquez · Ut Southwestern Medical Center · R33 · FY2023 · AG
Preventing Cognitive Decline by Reducing BP Target Trial (PCOT)
$1,238,148Miguel A Vazquez · Ut Southwestern Medical Center · R33 · FY2024 · AG
Chronic Kidney Diseases of Uncertain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - SDCC
$1,237,960Jill Lebov · Research Triangle Institute · U24 · FY2021 · DK
San Diego EXPORT Comprehensive NCMHD Research Center
$1,237,056Sandra P Daley · University Of California, San Diego · P60 · FY2010 · MD
San Diego EXPORT Comprehensive NCMHD Research Center
$1,236,692Sandra P Daley · University Of California, San Diego · P60 · FY2011 · MD
Metabolic effects and mechanisms for heart failure in South Asians
$1,236,554Alka M Kanaya · University Of California, San Francisco · R01 · FY2022 · HL
Pathobiology of Severe Pulmonary Hypertension
$1,235,893University Of Colorado Denver · P01 · FY2001 · HL